Apolipoprotein B genetic variants modify the response to fenofibrate: A GOLDN study

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3316-3323

  Wojczynski, Mary K ^a   Gao, Guimin ^a   Borecki, Ingrid ^b   Hopkins, Paul N ^c   Parnell, Laurence ^d   Lai, Chao Qiang ^d   Ordovas, Jose M ^d   Chung, B Hong ^a   Arnett, Donna K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Fenofibrate; Genetics of lipid lowering drugs and diet network; Polymorphism; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; FEMALE; FENOFIBRATE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 78149332747     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P001834     Document Type: Article

References (47)

1. Sarwar, N., J. Danesh, G. Eiriksdottir, G. Sigurdsson, N. Wareham, S. Bingham, S. M. Boekholdt, K. T. Khaw, and V. Gudnason. 2007. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 115: 450-458.
2. Chiodini, B. D., S. Barlera, M. G. Franzosi, V. L. Beceiro, M. Introna, and G. Tognoni. 2003. APO B gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis. 167: 355-366.
3. Ozturk, I. C., and A. A. Killeen. 1999. An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk. Arch. Pathol. Lab. Med. 123: 1219-1222.
4. Sofi, F., A. M. Gori, R. Marcucci, G. Innocenti, C. Dini, S. Genise, G. F. Gensini, R. Abbate, C. Surrenti, and A. Casini. 2007. Adherence to a healthful life attenuates lipid parameters among a healthy Italian population. Nutr. Metab. Cardiovasc. Dis. 17: 642-648.
5. Ford, E. S., C. Li, G. Zhao, W. S. Pearson, and A. H. Mokdad. 2009. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch. Intern. Med. 169: 572-578.
6. Robins, S. J., and H. E. Bloomfield. 2006. Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials. Curr. Opin. Lipidol. 17: 431-439.
7. Keating, G. M., and K. F. Croom. 2007. Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus. Drugs. 67: 121-153.
8. Zaman, M. M., S. Ikemoto, N. Yoshiike, C. Date, T. Yokoyama, and H. Tanaka. 1997. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study. Arterioscler. Thromb. Vasc. Biol. 17: 3495-3504.
9. Knott, T. J., S. C. Rall, Jr., T. L. Innerarity, S. F. Jacobson, M. S. Urdea, B. Levy-Wilson, L. M. Powell, R. J. Pease, R. Eddy, H. Nakai, et al. 1985. Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization. Science. 230: 37-43.
10. Fisher, W. R., L. A. Zech, and P. W. Stacpoole. 1994. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler. Thromb. 14: 501-510.
11. Olofsson, S. O., L. Asp, and J. Boren. 1999. The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr. Opin. Lipidol. 10: 341-346.
12. Brodsky, J. L., and E. A. Fisher. 2008. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol. Metab. 19: 254-259.
13. Rajput-Williams, J., T. J. Knott, S. C. Wallis, P. Sweetnam, J. Yarnell, N. Cox, G. I. Bell, N. E. Miller, and J. Scott. 1988. Variation of apolipoprotein- B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 2: 1442-1446.
14. Marshall, H. W., L. C. Morrison, L. L. Wu, J. L. Anderson, P. S. Corneli, D. M. Stauffer, A. Allen, L. A. Karagounis, and R. H. Ward. 1994. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation. 89: 567-577.
15. Higgins, M., M. Province, G. Heiss, J. Eckfeldt, R. C. Ellison, A. R. Folsom, D. C. Rao, J. M. Sprafka, and R. Williams. 1996. NHLBI Family Heart Study: objectives and design. Am. J. Epidemiol. 143: 1219-1228.
16. Pankow, J. S., M. A. Province, S. C. Hunt, and D. K. Arnett. 2002. Regarding "Testing for population subdivision and association in four case-control studies". Am. J. Hum. Genet. 71: 1478-1480. (Pubitemid 36015903)
17. Livak, K. J. 1999. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet. Anal. 14: 143-149.
18. Bentzen, J., P. Poulsen, A. Vaag, and M. Fenger. 2003. Further studies of the influence of apolipoprotein B alleles on glucose and lipid metabolism. Hum. Biol. 75: 687-703.
19. Perez-Martinez, P., F. Perez-Jimenez, J. M. Ordovas, C. Bellido, J. A. Moreno, P. Gomez, C. Marin, R. A. Fernandez de la Puebla, J. A. Paniagua, and J. Lopez-Miranda. 2007. The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population. Nutr. Metab. Cardiovasc. Dis. 17: 224-229.
20. Perez-Martinez, P., F. Perez-Jimenez, J. M. Ordovas, J. A. Moreno, C. Marin, R. Moreno, Y. Jimenez-Gomez, J. A. Paniagua, and J. Lopez-Miranda. 2007. Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population. Lipids. 42: 143-150.
21. Lopez-Miranda, J., J. M. Ordovas, M. A. Ostos, C. Marin, S. Jansen, J. Salas, A. Blanco-Molina, J. A. Jimenez-Pereperez, F. Lopez-Segura, and F. Perez-Jimenez. 1997. Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler. Thromb. Vasc. Biol. 17: 1765-1773.
22. Lopez-Miranda, J., C. Marin, P. Castro, P. Gomez, A. Gonzalez-Amieva, E. Paz, D. Bravo, J. M. Ordovas, J. Jimenez-Pereperez, and F. Perez-Jimenez. 2000. The effect of apolipoprotein B xbaI polymorphism on plasma lipid response to dietary fat. Eur. J. Clin. Invest. 30: 678-684.
23. Matys, V., E. Fricke, R. Geffers, E. Gossling, M. Haubrock, R. Hehl, K. Hornischer, D. Karas, A. E. Kel, O. V. Kel-Margoulis, et al. 2003. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31: 374-378.
24. Corbett, J., A. Kraja, I. B. Borecki, and M. A. Province. 2003. Use of a random coefficient regression (RCR) model to estimate growth parameters. BMC Genet. 4 (Suppl. 1): S5.
25. Laird, N. M., and J. H. Ware. 1982. Random-effects models for longitudinal data. Biometrics. 38: 963-974.
26. Littell, R. C., G. A. Milliken, W. W. Stroup, and R. D. Wolfinger. 1996. SAS System for Mixed Models. SAS Institute, Inc., Cary, NC.
27. Singer, J. D. 1998. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J. Educ. Behav. Stat. 24: 323-355.
28. Lai, C. Q., S. Demissie, L. A. Cupples, Y. Zhu, X. Adiconis, L. D. Parnell, D. Corella, and J. M. Ordovas. 2004. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J. Lipid Res. 45: 2096-2105.
29. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263-265.
30. Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J. C. Fruchart. 1998. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 98: 2088-2093.
31. Gylling, H., K. Kontula, U. M. Koivisto, H. E. Miettinen, and T. A. Miettinen. 1997. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler. Thromb. Vasc. Biol. 17: 38-44.
32. Jemaa, R., A. Mebazaa, and F. Fumeron. 2004. Apolipoprotein B signal peptide polymorphism and plasma LDL-cholesterol response to low-calorie diet. Int. J. Obes. Relat. Metab. Disord. 28: 902-905.
33. Heller, F., and C. Harvengt. 1983. Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. Eur. J. Clin. Pharmacol. 25: 57-63.
34. Staels, B., N. Vu-Dac, V. A. Kosykh, R. Saladin, J. C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
35. Caslake, M. J., C. J. Packard, A. Gaw, E. Murray, B. A. Griffin, B. D. Vallance, and J. Shepherd. 1993. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. Arterioscler. Thromb. 13: 702-711.
36. Guerin, M., E. Bruckert, P. J. Dolphin, G. Turpin, and M. J. Chapman. 1996. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 16: 763-772.
37. Ng, P. C., and S. Henikoff. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31: 3812-3814.
38. Sunyaev, S., V. Ramensky, I. Koch, W. Lathe 3rd, A. S. Kondrashov, and P. Bork. 2001. Prediction of deleterious human alleles. Hum. Mol. Genet. 10: 591-597.
39. Windler, E., and R. J. Havel. 1985. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J. Lipid Res. 26: 556-565.
40. Wang, C. S., W. J. McConathy, H. U. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.
41. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
42. Aalto-Setala, K., K. Kontula, M. Manttari, J. Huttunen, V. Manninen, P. Koskinen, and H. M. Frick. 1991. DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment. Clin. Pharmacol. Ther. 50: 208-214.
43. Watts, G. F., P. H. Barrett, J. Ji, A. P. Serone, D. C. Chan, K. D. Croft, F. Loehrer, and A. G. Johnson. 2003. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Diabetes. 52: 803-811.
44. Jensen, L. J., M. Kuhn, M. Stark, S. Chaffron, C. Creevey, J. Muller, T. Doerks, P. Julien, A. Roth, M. Simonovic, et al. 2009. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37: D412-D416.
45. Islam, M. S., O. T. Raitakari, M. Juonala, M. Kahonen, N. Hutri-Kahonen, A. Collings, K. Aalto-Setala, K. Kontula, J. Marniemi, J. S. Viikari, et al. 2005. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 180: 79-86.
46. Scartezini, M., M. A. Zago, E. A. Chautard-Freire-Maia, A. Pazin-Filho, J. A. Marin-Neto, J. K. Hotta, A. J. Nascimento, and J. E. Dos-Santos. 2003. The X-X-/E+E+ genotype of the XbaI/EcoRI polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample. Braz. J. Med. Biol. Res. 36: 369-375.
47. Misra, A., S. Nishanth, S. T. Pasha, R. M. Pandey, P. Sethi, and D. S. Rawat. 2001. Relationship of Xba1 and EcoR1 polymorphisms of apolipoprotein-B gene to dyslipidemia and obesity in Asian Indians in North India. Indian Heart J. 53: 177-183.